Company / Book Value per Share
Moderna Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$22.409
FY2025
5-year range
$2.945 / $35.984
FY2021-FY2025
Trend
-21.5%
vs FY2024
Sector context
#22 of 209
Health Care
What the data says
Moderna's book value per share of $22.409 is higher than 89% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from -$8.549 in FY2017 to $35.984 in FY2023.
Based on SEC 10-K filings.
$22.409 in FY2025 with a 5-year CAGR of +24.1%. Top quartile in the Health Care sector.
Declined from $35.984 to $22.409 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +52.2%
- 5-Year CAGR
- +24.1%
- 10-Year CAGR
- -
Sector benchmark
-88.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.1%, indicating consistent growth.
- In FY2025, book value per share decreased 21.5% year-over-year.
- Ranks #22 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.409 | -21.5% |
| FY2024 | $28.537 | -20.7% |
| FY2023 | $35.984 | +466.3% |
| FY2022 | $6.355 | +115.8% |
| FY2021 | $2.945 | -61.3% |
| FY2020 | $7.61 | +112.9% |
| FY2019 | $3.574 | -84.8% |
| FY2018 | $23.464 | +374.5% |
| FY2017 | -$8.549 | -55.1% |
| FY2016 | -$5.512 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026